Clinical Trial Update: Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating deferasirox with deferoxamine followed by deferasirox alone for severe cardiac iron overload; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)
• Deferoxamine (deferoxamine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Cardiac Iron Overload | Phase 2 | Status: COMPLETED | Results posted: 2021-06-24